Simultaneous Care: Linking Palliation to Clinical Trials
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/28/2017 |
| Start Date: | February 2002 |
| End Date: | December 2013 |
A Randomized Control Trial That Teaches Oncology Clinical Trial Patients and Their Caregivers Problem Solving Skills.
This is a multi-site randomized control trial taking place at six cancer centers. UC Davis
is the lead site. Additional performance sites include the City of Hope Medical Center, Fred
Hutchinson Cancer Center at the Univ. of Washington, USC Norris Cancer Center, UCSD Cancer
Center, and Johns Hopkins Cancer Center. Clinical trial patients and their caregivers who
are randomized to the intervention arm of the study are scheduled for three educational
sessions. The sessions focus on teaching problem solving skills based on the COPE problem
solving model.
is the lead site. Additional performance sites include the City of Hope Medical Center, Fred
Hutchinson Cancer Center at the Univ. of Washington, USC Norris Cancer Center, UCSD Cancer
Center, and Johns Hopkins Cancer Center. Clinical trial patients and their caregivers who
are randomized to the intervention arm of the study are scheduled for three educational
sessions. The sessions focus on teaching problem solving skills based on the COPE problem
solving model.
The project introduces and evaluates the effects of a Simultaneous Care Education
Intervention, using the COPE model (Creativity, Optimism, Planning and Expert Information)
developed by D'Zurilla and Nezu, as one of its key components for cancer patients in Phase
I, II and III clinical trials. The SCEI team will use the COPE problem solving educational
model to instruct patients on how to problem solve and manage challenges associated not only
with the investigational therapy, but also the psychosocial issues that arise from cancer
diagnosis, disease progression, treatment, and disease or treatment related symptoms. The
educational intervention also sets up a system for regularly contacting the patient and
caregiver in order to reinforce what is taught. Patients and caregivers randomized to the
intervention arm will receive three education sessions. Patients and designated caregiver
will be asked to complete the set of measurement tools approximately every 30 days while
enrolled in the study.
Intervention, using the COPE model (Creativity, Optimism, Planning and Expert Information)
developed by D'Zurilla and Nezu, as one of its key components for cancer patients in Phase
I, II and III clinical trials. The SCEI team will use the COPE problem solving educational
model to instruct patients on how to problem solve and manage challenges associated not only
with the investigational therapy, but also the psychosocial issues that arise from cancer
diagnosis, disease progression, treatment, and disease or treatment related symptoms. The
educational intervention also sets up a system for regularly contacting the patient and
caregiver in order to reinforce what is taught. Patients and caregivers randomized to the
intervention arm will receive three education sessions. Patients and designated caregiver
will be asked to complete the set of measurement tools approximately every 30 days while
enrolled in the study.
Inclusion Criteria:
- English speaking, must have caregiver who is willing to participate, must be entering
a phase 1-3 oncology clinical trial. Must be able to complete first educational
session on or before treatment start date. Solid tumor or lymphoma only.
Exclusion Criteria:
- Non-English speaking, no caregiver available, unable to complete first educational
session on or before treatment start date.
We found this trial at
1
site
Click here to add this to my saved trials
